View Item 

Show simple item record

Patterns of Drug Utilization in a Neonatal Intensive Care Unit

dc.contributor.authorWarrier, Indulekhaen_US
dc.contributor.authorDu, Weien_US
dc.contributor.authorNatarajan, Girijaen_US
dc.contributor.authorSalari, Valien_US
dc.contributor.authorAranda, Jacoben_US
dc.date.accessioned2013-04-08T20:49:36Z
dc.date.available2013-04-08T20:49:36Z
dc.date.issued2006-04en_US
dc.identifier.citationWarrier, Indulekha; Du, Wei; Natarajan, Girija; Salari, Vali; Aranda, Jacob (2006). "Patterns of Drug Utilization in a Neonatal Intensive Care Unit." The Journal of Clinical Pharmacology 46(4). <http://hdl.handle.net/2027.42/97176>en_US
dc.identifier.issn0091-2700en_US
dc.identifier.issn1552-4604en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97176
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherBlackwell Publishing Ltden_US
dc.subject.otherNeonateen_US
dc.subject.otherNeonatal Intensive Care Uniten_US
dc.subject.otherDrug Utilizationen_US
dc.titlePatterns of Drug Utilization in a Neonatal Intensive Care Uniten_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationotherDivision of Neonatology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan.en_US
dc.contributor.affiliationotherDivision of Pediatric Clinical Pharmacology, Children's Hospital of Michigan, Wayne State University, Detroit, Michigan.en_US
dc.identifier.pmid16554453en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97176/1/0091270005285456.pdf
dc.identifier.doi10.1177/0091270005285456en_US
dc.identifier.sourceThe Journal of Clinical Pharmacologyen_US
dc.identifier.citedreferenceAlexander GR, Kogan M, Bader D, Carlo W, Allen M, Mor J. US birth weight/gestational age‐specific neonatal mortality: 1995–1997 rates for whites, Hispanics, and blacks. Pediatrics. 2003; 111: e61 – 6.en_US
dc.identifier.citedreferenceEarly neonatal drug utilization in preterm newborns in neonatal intensive care units. Italian Collaborative Group on Preterm Delivery. Dev Pharmacol Ther. 1988; 11: 1 – 7.en_US
dc.identifier.citedreferenceBlumer JL, Reed MD. Principles of neonatal pharmacology. In: Yaffe SJ, Aranda JV, eds. Neonatal and Pediatric Pharmacology. 3rd ed. Baltimore: Lippincott, Williams & Wilkins; 2005: 146 – 158.en_US
dc.identifier.citedreferencevan den Anker, JN. Managing drugs safely. Semin Fetal Neonatal Med. 2005; 10: 73 – 81.en_US
dc.identifier.citedreferenceKnight M. Adverse drug reactions in neonates. J Clin Pharmacol. 1994; 34: 128 – 135.en_US
dc.identifier.citedreferenceAranda JV. Factors associated with adverse drug reactions in the newborn. Pediatr Pharmacol 1983; 3: 245 – 249.en_US
dc.identifier.citedreferenceAranda JV, Clarkson S, Collinge JM. Changing pattern of drug utilization in a neonatal intensive care unit. Am J Perinatol. 1983; 1: 28 – 30.en_US
dc.identifier.citedreferenceDaniell AJ, Darlow BA. Audit of drug usage in a regional neonatal intensive care unit. Aust Paediatr J. 1989; 25: 207 – 210.en_US
dc.identifier.citedreferenceKaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very‐low‐birth‐weight infants. Clin Microbiol Rev. 2004; 17: 638 – 680.en_US
dc.identifier.citedreferenceRoilides E, Farmaki E, Evdoridou J, et al. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis. 2004; 23: 745 – 750.en_US
dc.identifier.citedreferenceKossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998; 17: 504 – 508.en_US
dc.identifier.citedreferenceStratov I, Gottlieb T, Bradbury R, O'Kane GM. Candidaemia in an Australian teaching hospital: relationship to central line and TPN use. J Infect. 1998; 36: 203 – 207.en_US
dc.identifier.citedreferenceJohnsson H, Ewald U. The rate of candidaemia in preterm infants born at a gestational age of 23–28 weeks is inversely correlated to gestational age. Acta Paediatr. 2004; 93: 954 – 958.en_US
dc.identifier.citedreferenceGlover DD, Amonkar M, Rybeck BF, Tracy TS. Prescription, over‐the‐counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol. 2003; 188: 1039 – 1045.en_US
dc.identifier.citedreferenceHenry A, Crowther C. Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol. 2000; 40: 165 – 172.en_US
dc.identifier.citedreferenceStevenson DK, Verter J, Fanaroff AA, et al. Sex differences in outcomes of very low birthweight infants: the newborn male disadvantage. Arch Dis Child Fetal Neonatal Ed. 2000; 83: F182 – F185.en_US
dc.identifier.citedreferenceSpitzer AR, Kirkby S, Kornhauser M. Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol. 2005; 25: 265 – 269.en_US
dc.identifier.citedreferenceToledano H, Schlesinger Y, Raveh D, et al. Prospective surveillance of vancomycin‐resistant enterococci in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis. 2000; 19: 282 – 287.en_US
dc.identifier.citedreferenceKarlowicz MG, Buescher ES, Surka AE. Fulminant late‐onset sepsis in a neonatal intensive care unit, 1988–1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics. 2000; 106: 1387 – 1390.en_US
dc.identifier.citedreferenceDasgupta SJ, Gill AB. Hypotension in the very low birthweight infant: the old, the new, and the uncertain. Arch Dis Child Fetal Neonatal Ed. 2003; 88: F450 – F454.en_US
dc.identifier.citedreferenceBrion LP, Primhak RA, Ambrosio‐Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2002; 1: CD001817.en_US
dc.identifier.citedreferenceKaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001; 285: 2114 – 2120.en_US
dc.identifier.citedreferenceGonzalez‐Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients: a prospective study. Int J Clin Pharmacol Ther. 1998; 36: 530 – 533.en_US
dc.identifier.citedreferenceMartinez‐Mir I, Garcia‐Lopez M, Palop V, Ferrer JM, Rubio E, Olivas FJ Morales A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol. 1999; 47: 681 – 688.en_US
dc.identifier.citedreferenceRoberts R, Rodriguez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003; 290: 905 – 911.en_US
dc.identifier.citedreferenceHines RN, McCarver DG. The ontogeny of human drug‐metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther. 2002; 300: 355 – 360.en_US
dc.identifier.citedreferenceMcCarver DG, Hines RN. The ontogeny of human drug‐metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther. 2002; 300: 361 – 366.en_US
dc.identifier.citedreferenceTen Eick AP, Reed MD. Clinical pharmacology research in the pediatric patient: the challenge continues. Prog Pediatr Cardiol. 2000; 12: 29 – 35.en_US
dc.identifier.citedreferenceChoonara I. Unlicensed and off‐label drug use in children: implications for safety. Expert Opin Drug Saf. 2004; 3: 81 – 83.en_US
dc.identifier.citedreferenceAssael BM. Therapeutic orphans: European perspective. Pediatrics. 1999; 104 (Pt 2): 591 – 592.en_US
dc.identifier.citedreferenceSurvey of the current state of pediatric drug use in Japan (1994–6). Drug Therapy Committee of the Japan Pediatric Society. Pediatr Int. 2000; 42: 109 – 113.en_US
dc.identifier.citedreferenceBonati M. Epidemiologic evaluation of drug use in children. J Clin Pharmacol. 1994; 34: 300 – 305.en_US
dc.identifier.citedreferenceGortner L. Drug utilisation in preterm and term neonates. Pharmacoeconomics. 1993; 4: 437 – 445.en_US
dc.identifier.citedreferenceLesko SM, Epstein MF, Mitchell AA. Recent patterns of drug use in newborn intensive care. J Pediatr. 1990; 116: 985 – 990.en_US
dc.identifier.citedreferenceAranda JV, Cohen S, Neims AH. Drug utilization in a newborn intensive care unit. J Pediatr. 1976; 89: 315 – 317.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
0091270005285456.pdf
Size:
93.13KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.